SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2018

Accounting Standards Update 2014-09 | Restatement of beginning balances

Summary of impacts of adoption of recent accounting pronouncements

		Balance at				Balance at
		December 31, 2017		Adjustment		January 1, 2018
Consolidated Balance Sheets
Assets
Inventories	$	337,216	$	(14,637)	$	322,579
Prepaid and other		109,791		13,984		123,775
Liabilities
Accounts payable and accrued liabilities		461,579		(5,706)		455,873
Deferred income taxes		20,995		1,292		22,287
Deferred and other non-current liabilities		5,608		824		6,432
Stockholders’ Equity
Retained earnings		1,301,147		2,937		1,304,084

Accounting Standards Update 2014-09 | Cumulative effect of change

Summary of impacts of adoption of recent accounting pronouncements

	For the Three Months Ended June 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Statements of Income
Net Sales
Beauty + Home	$	368,536	$	370,267	$	(1,731)
Pharma		241,209		241,311		(102)
Food + Beverage		100,863		100,859		4
Costs and Expenses
Cost of sales (exclusive of depreciation and amortization)		464,244		465,343		(1,099)
Provision for income taxes		19,117		19,347		(230)
Net income		55,781		56,281		(500)

	For the Six Months Ended June 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Statements of Income
Net Sales
Beauty + Home	$	746,709	$	747,135	$	(426)
Pharma		471,336		471,773		(437)
Food + Beverage		195,913		195,959		(46)
Costs and Expenses
Cost of sales (exclusive of depreciation and amortization)		920,066		920,243		(177)
Provision for income taxes		41,046		41,272		(226)
Net income		115,069		115,575		(506)

	June 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Balance Sheets
Assets
Inventories	$	343,170	$	357,630	$	(14,460)
Prepaid and other		104,998		90,862		14,136
Liabilities
Accounts payable and accrued liabilities		509,118		513,458		(4,340)
Deferred income taxes		19,586		18,520		1,066
Deferred and other non-current liabilities		6,642		6,123		519
Stockholders’ Equity
Retained earnings		1,328,034		1,325,603		2,431

Accounting Standards Update 2017-07

Summary of impacts of adoption of recent accounting pronouncements

	Original				Revised
	Balance		Adjustment		Balance
Revised Condensed Consolidated Statements of Income
Three Months Ended June 30, 2017
Cost of sales (exclusive of depreciation and amortization)	$	399,954	$	(290)	$	399,664
Selling, research & development and administrative		95,659		(203)		95,456
Total Operating Expenses		532,855		(493)		532,362
Operating Income		84,891		493		85,384
Miscellaneous, net		1,768		(493)		1,275
Total Other (Expense) Income		(5,323)		(493)		(5,816)
Income before Income Taxes		79,568		—		79,568
Six Months Ended June 30, 2017
Cost of sales (exclusive of depreciation and amortization)	$	784,886	$	(538)	$	784,348
Selling, research & development and administrative		197,175		(437)		196,738
Total Operating Expenses		1,056,634		(975)		1,055,659
Operating Income		162,428		975		163,403
Miscellaneous, net		1,691		(975)		716
Total Other (Expense) Income		(13,380)		(975)		(14,355)
Income before Income Taxes		149,048		—		149,048